When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HALO - Janssen files U.S. application for subcutaneous Darzalex
Halozyme Therapeutics Inc.
Genmab A/S (OTCPK:GNMSF) announces that licensee Janssen Biotech, a unit of Johnson & Johnson (JNJ-5.2%), has filed a marketing application with the FDA seeking approval for a subcutaneously administered formulation of multiple myeloma med Darzalex (daratumumab).
More news on: Genmab A/S, Johnson & Johnson, Halozyme Therapeutics, Inc., Healthcare stocks news,